FDA Panel Mulls Merck COVID-19 Antiviral Pill
Expert panel voted on whether to recommend authorizing the drug for high-risk patients
Related Articles
Most Cancer Drugs Granted Accelerated Approval Don’t Confer a Clinical Benefit – Renal and Urology News
Most cancer drugs that receive accelerated approval from the FDA do not confer a clinical benefit within 5 years of approval, data suggest.
TILT-123 Shows Early Activity in Advanced Cancers – Renal and Urology News
TILT-123 (igrelimogene litadenorepvec) has demonstrated activity in heavily pretreated patients with advanced cancers in a phase 1 trial.
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury – Renal and Urology News
Simple risk score, including nine covariates, predicted risk for CP-AKI in monotonic manner in derivation, validation cohorts
Continuous Glucose Monitors Cut Hospitalizations in Type 2 Diabetes, CKD – Renal and Urology News
Glycemic variability in patients with diabetes and chronic kidney disease can lead to hypoglycemic or hyperglycemic crises.
Accelerated Hepatitis B Vaccination Appears Safe, Effective in CKD – Renal and Urology News
Patients with accelerated HBV vaccination who experience seroconversion might be eligible to receive a kidney transplant from a hepatitis B-positive donor.
Tirzepatide vs Semaglutide Linked to Lower Metabolic Syndrome Prevalence – Renal and Urology News
Researchers conducted a post hoc analysis of the SURPASS clinical trial program to compare the effects of tirzepatide and semaglutide on metabolic syndrome prevalence.
FDA Approves Antibiotic Zevtera to Treat Multiple Serious Infections – Renal and Urology News
The approval was based on data from multiple studies, including ERADICATE, TARGET, and a phase 3 study in CABP.
Guidelines Developed for Catheter Ablation of Atrial Fibrillation – Renal and Urology News
Patients should have an electrocardiogram and echocardiogram before the procedure; should receive anticoagulation after
Sotagliflozin Reduces Stroke Risk in Patients With Diabetes, CKD – Renal and Urology News
Preliminary findings indicate that sotagliflozin has an anti-clotting effect.
Clinically Significant Prostate Cancers Found Despite Low PSA – Renal and Urology News
Recent study raises questions about the use of MRI as a first-line screening test.